Purchase Order 75N94020P00579
Award Date
8/4/20
Potential Completion Date
12/28/20
Potential Value
$18K
Funding Federal Agency
National Institute on Alcohol Abuse and Alcoholism
Contracting Federal Agency
National Institute of Child Health and Human Development
Awardee
Brainxell, Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
PSC Category
6505 - Drugs And Biologicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Madison, WI 53711, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Brainxell, Inc., a for-profit manufacturer of human neuron cells and related services to support neurological disease research and drug discovery. The contract, valued at $18,725.00, was awarded by the National Institute on Drug Abuse, a part of the National Institutes of Health (NIH), under a small business set-aside. Brainxell will provide human neuron cells, customized neuron cell lines, and associated services to enable research on neuronal infectivity...
This contract award to Brainxell, Inc., a for-profit manufacturer of specialized human neuron cells, was made by the Department of Health and Human Services' National Institutes of Health (NIH) National Center for Advancing Translational Sciences. The $130,500.00 firm fixed-price purchase order includes the generation of a stable EGFP-expressing induced pluripotent stem cell (iPSC) line, differentiation of iPSCs into spinal motor neurons, and associated shipping services. This work supports...
The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, awarded a $100,000.00 firm fixed-price purchase order contract to Brainxell, Inc., a for-profit manufacturer of human neuron cells. The contract is for the provision of human cortical glutamatergic neurons to support research on neurological disease and SARS-CoV-2 infectivity. Brainxell, as a prime contractor, has previously received grant awards from...
This federal contract award to Brainxell, Inc. for $81,450.00 was issued by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to provide 40 vials of human midbrain dopaminergic cells derived from induced pluripotent stem cells (iPSCs) in two batches. The contract, which did not have a set-aside designation, was awarded on a firm fixed-price basis and included a 10% total price discount. Brainxell, a for-profit manufacturer...
This is a $100,000 firm fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Brainxell, Inc. to provide human cortical glutamatergic neurons derived from induced pluripotent stem cells (iPSCs). The neurons will be used by NCATS' Therapeutics for Rare and Neglected Diseases (TRND) program to study the pathophysiology of NGLY1 deficiency, a rare multi-system disease, and perform high-throughput...
This is a firm-fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Brain Research And Development Services LTD, a foreign-owned for-profit organization that manufactures goods. The contract has a ceiling value of $90,000.00 and a period of performance through May 30, 2017. It does not have a set-aside designation. The contract was awarded on September 24, 2015 and is related to the BRAIN (Brain Research through Advancing Innovative...
This is a firm-fixed-price purchase order awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $25,000.00, is for the supply of Inscopix nVue 2.0 Systems, which are advanced neuroscience research technologies that enable simultaneous visualization and manipulation of neural activity in behaving subjects. Inscopix, Inc., a for-profit scientific instrument and services provider,...
This is a firm fixed price purchase order for $62,952.00 awarded by the National Institute on Drug Abuse, a civilian federal agency, to Neuroscience Associates Inc. to provide neurohistology, imaging, and image analysis services on human "minibrain" tissue samples. This award is not associated with a larger contract vehicle and does not have a set-aside designation. Neuroscience Associates Inc. is a for-profit organization that specializes in mass production neurohistology services,...
This is a firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $24,250.00, is for the delivery of Brainbox LTD's NEUROFUS DEEP TRANSDUCER, a specialized medical device used to modulate neural activity in deeper areas of the human brain. This technology supports NIDA's research efforts, which include the study of addiction and other neurological conditions. The...
This contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse to Applied Stemcell, Inc., a minority-owned, woman-owned small business, for a firm-fixed-price purchase order in the amount of $63,000.00. The contract calls for the use of CRISPR gene editing technology to create two custom induced pluripotent stem cell (iPSC) reporter cell lines - one with dual gene knock-ins for albumin and alpha-fetoprotein, and...